News & Updates
Filter by Specialty:
Baricitinib, ivermectin, favipiravir rank high among COVID-19 oral antivirals
15 Dec 2023
byAudrey Abella
Baricitinib, ivermectin, and favipiravir stood out in terms of efficacy in a network meta-analysis evaluating various novel oral antivirals for the treatment of COVID-19.
Baricitinib, ivermectin, favipiravir rank high among COVID-19 oral antivirals
15 Dec 2023NPAR, NLR predict risk of death in COPD patients
14 Dec 2023
Increased neutrophil-percentage-to-albumin ratio (NPAR) and neutrophil-to-lymphocyte ratio (NLR) appear predictive of mortality risks in community-dwelling adults with chronic obstructive pulmonary disease (COPD), suggests a US study.
NPAR, NLR predict risk of death in COPD patients
14 Dec 2023AFP-L3, DCP predict HCC recurrence after liver transplant
13 Dec 2023
Dual positivity for alpha-fetoprotein (AFP) bound to Lens culinaris agglutinin (AFP-L3) ≥15 percent and des-gamma-carboxyprothrombin (DCP) ≥7.5 can strongly predict majority of early hepatocellular carcinoma (HCC) recurrences following liver transplantation (LT), suggests a study.